RISK FACTORS FOR PROGRESSION OF CHRONIC RENAL DISEASE
RISK FACTORS FOR PROGRESSION OF CHRONIC RENAL DISEASE
批准号:
2444173
负责人:
MACKENZIE WALSER
金额:
$14.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-20 至 1999-06-30
关键词:
antihypertensive agents blood chemistry chronic renal failure clinical research corticosteroids dehydroepiandrosterone diet therapy dietary proteins disease /disorder proneness /risk enzyme linked immunosorbent assay glomerular filtration rate high density lipoproteins human subject human therapy evaluation hypertension mathematical model nitrates polycystic kidney proteinuria racial /ethnic difference transferrin transforming growth factors tryptophan urinalysis urinary tract disorder chemotherapy
中文摘要
描述:
英文摘要
DESCRIPTION:
Rates of progression vary widely among patients with chronic renal failure.
In most series, at least 15% of patients do not progress at all for years;
at the other extreme, some patients lose glomerular filtration rates (GFR's)
as rapidly as three ml/min/mo. Previous studies, entitled "Modification of
Diet in Renal Disease (MDRD)," have randomized 925 patients to various diets
and blood pressure targets and followed them for an average of two years
with sequential GFR's. This data set is unique in having documented greater
than 6,000 GFR's. Multivariate analysis of the determinants of rates of
progression among these patients has so far been able to account for no more
than a small proportion of the variability in observed rates of progression.
In another series of 104 patients, the applicant has identified four
analyses whose levels correlate strongly with rates of progression: serum
free tryptophan, serum dehydroepiandrosterone sulfate, urinary nitrate, and
urinary 17-hydroxycorticosteroids. They propose to measure these analyses
plus serum transforming growth factors in frozen samples from the
feasibility and full-scale MDRD studies, and to determine by regression
techniques how much of the observed variability in progression rates can be
accounted for by these analyses. The extent to which this predictive power
is independent of presently identified predictors of renal disease
progression will be studied. They will also determine whether these
analyses were altered by the dietary and blood pressure interventions of the
MDRD studies, and the extent to which these analyses explain the observed
association of achieved blood pressure and achieved protein intake with
progression. The applicant indicates that the results will have important
implications for the understanding the pathogenesis of progression and may
point to new therapeutic approaches to slowing progression.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Effects of a supplemented very low protein diet in predialysis patients on the serum albumin level, proteinuria, and subsequent survival on dialysis.
透析前患者补充极低蛋白饮食对血清白蛋白水平、蛋白尿和随后透析生存的影响。
DOI:
10.1159/000057352
发表时间:
1998
期刊:
Mineral and electrolyte metabolism.
影响因子:
--
作者:
[Walser,M]
通讯作者:
Walser,M
Nutritional Therapy of the Nephrotic Syndrome
-
批准号:7044578
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2003
-
负责人:MACKENZIE WALSER
-
依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
-
批准号:6218187
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
-
批准号:6114276
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF DHEA IN CHRONIC RENAL FAILURE
-
批准号:6114381
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF KETOCONAZOLE + PREDNISONE ON PROGRESSION OF CHRONIC RENAL F
-
批准号:6114377
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF DHEA IN CHRONIC RENAL FAILURE
-
批准号:6297554
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
-
批准号:6297503
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF DHEA IN CHRONIC RENAL FAILURE
-
批准号:6218292
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MACKENZIE WALSER
-
依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
-
批准号:6275511
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:MACKENZIE WALSER
-
依托单位:
NUTRITIONAL THERAPY OF CHRONIC RENAL FAILURE IN OUTPATIENTS
-
批准号:6245405
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF DHEA IN CHRONIC RENAL FAILURE
-
批准号:6275616
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:MACKENZIE WALSER
-
依托单位:
SECOND RENAL BIOPSY IN PREVIOUS NEPHROTIC SYNDROME TREATED PATIENTS
-
批准号:6245464
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:MACKENZIE WALSER
-
依托单位:
PHASE II TRIAL OF KETOCONAZOLE + PREDNISONE ON PROGRESSION OF CHRONIC RENAL F
-
批准号:6275612
-
项目类别:
-
资助金额:$2.01万
-
财政年份:1997
-
负责人:MACKENZIE WALSER
-
依托单位:
RISK FACTORS FOR PROGRESSION OF CHRONIC RENAL DISEASE
-
批准号:2152775
-
项目类别:
-
资助金额:$14.91万
-
财政年份:1996
-
负责人:MACKENZIE WALSER
-
依托单位:
EFFECT OF DIET ON PROGRESSION OF CHRONIC RENAL FAILURE
-
批准号:3550717
-
项目类别:
-
资助金额:$11.12万
-
财政年份:1984
-
负责人:MACKENZIE WALSER
-
依托单位:
EFFECT OF DIET ON PROGRESSION OF CHRONIC RENAL FAILURE
-
批准号:3550718
-
项目类别:
-
资助金额:$63.4万
-
财政年份:1984
-
负责人:MACKENZIE WALSER
-
依托单位:
EFFECT OF DIET ON PROGRESSION OF CHRONIC RENAL FAILURE
-
批准号:3548287
-
项目类别:
-
资助金额:$60.92万
-
财政年份:1984
-
负责人:MACKENZIE WALSER
-
依托单位:
EFFECT OF DIET ON PROGRESSION OF CHRONIC RENAL FAILURE
-
批准号:3550716
-
项目类别:
-
资助金额:$59.33万
-
财政年份:1984
-
负责人:MACKENZIE WALSER
-
依托单位:
KETO-ANALOGUE INCORPORATION INTO PROTEINS
-
批准号:3152401
-
项目类别:
-
资助金额:$15.31万
-
财政年份:1983
-
负责人:MACKENZIE WALSER
-
依托单位:
KETOACID THERAPY OF RENAL FAILURE
-
批准号:3230473
-
项目类别:
-
资助金额:$28.28万
-
财政年份:1983
-
负责人:MACKENZIE WALSER
-
依托单位:
海外基金